• About Us
      • Back
      • History
          • Back
          • Company background
          • Path to success
          • Milestones in Biohit’s history
      • Biohit Management
      • Quality
      • Research and Development
      • Career
      • Glossary
      • News and Events
      • Privacy policy
  • Products
      • Back
      • Diagnostic tests
          • Back
          • GastroPanel ELISA
          • Biohit Active B12 ELISA
          • Biohit Total 25OH Vitamin D ELISA
          • Biohit Calprotectin ELISA
          • Helicobacter Pylori Quick Test
          • Helicobacter Pylori UFT300 Quick Test
          • ColonView Quick Test
          • Lactose Intolerance Quick Test
          • Celiac Disease Quick Test
      • Monoclonal Antibodies
      • Acetaldehyde Binding Products
          • Back
          • Acetium lozenge
          • Acetium capsule
      • Dysbiosis
          • Back
          • GA-map Dysbiosis Test
      • Instruments
          • Back
          • Microplate Readers and Washers
          • Quick Test Readers
          • ELISA Automates
      • Product Brochures
  • Scientific
      • Back
      • Key Biohit studies
      • Study protocols
      • Presentations
      • Literature
  • Laboratory
      • Back
      • Determination of Acetaldehyde
      • How to reduce acetaldehyde exposure
  • Investors
      • Back
      • Strategy
          • Back
          • Short term risks and uncertainty factors
          • Outlook for 2019
          • Operating Environment
      • Shareholders
          • Back
          • Number Dispersion
          • Notifications on major holdings
          • Holding Distribution
          • Insider Regulations
          • Insider Register
          • Major Shareholders
      • Financials
          • Back
          • Key Ratios
          • Financial reports
          • Profit share proposal
          • Annual Reports
      • Share Information
          • Back
          • Share Capital
          • Redemption Rights
          • Share Monitor
          • Share History
      • Group Management
          • Back
          • President
          • Board of Directors
          • Subsidiary management
          • Management
      • Corporate Governance
      • Stock Exchange Releases
          • Back
          • Order Releases
      • Fact sheet for investors
          • Back
          • IR calender
  • Partnering
      • Back
      • Acetium partnering
      • GastroPanel partnering
  • Contact
      • Back
      • Locations
      • Distributors
    • Finnish

Notifications on major holdings

08.06.2018 15:45 Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

08.06.2018 15:40 Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section10

08.06.2018 15:30 Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

08.06.2018 15:30 Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

08.06.2018 15:15 Biohit Oyj: Managers’ Transactions

08.06.2018 15:15 Biohit Oyj: Managers’ Transactions

08.06.2018 15:00 Biohit Oyj: Managers’ Transactions

08.06.2018 14:40 Biohit Oyj: Managers’ Transactions

Biohit Oyj
Laippatie 1, Helsinki, Finland
+358 9 773 861
info(at)biohit.fi
Subsidiary sites
Biohit Healthcare Ltd (UK) | Biohit Healthcare Srl (italy)
To Top
© 2019 Biohit Oyj, All rights reserved.
Legal Notice | Privacy Policy | Cookies
Privacy policyOkPrivacy policy